Formulation and evaluation of mucoadhesive microspheres of metronidazole

Authors

  • Dheeraj D. Chechare Department of Pharmaceutical Sciences, Bhagwant University, Rajasthan
  • M. Siddaiah Jawaharlal Nehru Technological University Anantapur, Anantapuram, Andhra Pradesh

DOI:

https://doi.org/10.18231/j.joapr.2024.12.1.93.99

Keywords:

Metronidazole, mucoadhesive microspheres, Chitosan, Sodium alginate, Sodium carboxymethyl cellulose, drug delivery

Abstract

Objective: Develop and evaluate mucoadhesive microspheres using Chitosan, Sodium alginate, and Sodium carboxymethyl cellulose (NaCMC) for sustained oral delivery of Metronidazole, aiming to improve bioavailability. Methods: Metronidazole-loaded microspheres were prepared via ionotropic gelation method with varying polymer ratios. Particle size, entrapment efficiency, swelling index, mucoadhesion (sheep mucosae), morphology (SEM), in-vitro wash-off test, drug release profile, and stability (6 months) were evaluated. Results: Chitosan content positively correlated with microsphere size. Entrapment efficiency ranged from 51.43% to 94.15%. Chitosan-based formulations, especially MTZ-7 (Chitosan:NaCMC, 3:1), displayed the highest mucoadhesion. SEM analysis revealed rough, spherical microspheres with a continuous polymeric coat. In-vitro wash-off test demonstrated prolonged residence time for Chitosan formulations. Sustained drug release was observed throughout the study, with MTZ-7 exhibiting the most desirable release profile. Stability studies showed no significant changes in drug release for selected formulations after 6 months. Conclusions: Chitosan-based microspheres, particularly MTZ-7, demonstrated superior mucoadhesive properties, sustained and controlled drug release, and desirable stability. These findings suggest the potential of Chitosan-based microspheres as a promising oral drug delivery system for Metronidazole, potentially addressing bioavailability concerns and improving therapeutic efficacy.

Downloads

Download data is not yet available.

References

Wagh RT, Jadhav SL, Banerjee SK, Gaikwad DD. Mucoadhesive Microsphere: A Review. International Journal of Pharmaceutical Excellence, 1(1), 26-44 (2014).

Carvalho FC, Bruschi ML, Evangelista RC, Gremio MP. Mucoadhesive drug delivery system. Brazilian Journal of Pharmaceutical Sciences, 46(1), 1-17 (2010).

Huang Y, Li X, Tong Y, Li J. Mucoadhesive microspheres of chitosan/carboxymethyl chitosan for oral delivery of tetracycline hydrochloride: Preparation, characterization and in vitro evaluation. Carbohydrate Polymers, 98(2), 1422-1430 (2013).

Kaur P, Kaur S, Singal G. Chitosan-based nanoparticles for targeted delivery of raloxifene: design, development, and characterization. Journal of Drug Delivery Science and Technology, 53, 101257 (2019).

Abdelrahman SH, Abdel-Aziz RE, Abdelbary AA, Eissa HS. Design and in vitro evaluation of mucoadhesive microspheres for nasal delivery of loratadine. Journal of Drug Delivery Science and Technology, 44, 74-83 (2018).

Learoyd TP, Burrows JL, French E, Seville PC. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. European Journal of Pharmaceutics and Biopharmaceutics, 68, 224-34 (2008).

Lynne W, John HC, John TF. Amoxycillin release from a floating dosage form based on alginates. International Journal of Pharmaceutics, 210 (1),45-49 (2000).

Joshi VC, Khan IA, Maged HM. Use of scanning electron microscopy in the authentication of botanicals. Pharmacopeial Forum, 34, 1075-1078 (2008).

Liu Z, Zhang Z, Huo M, Li J, He H. Mucoadhesive thiolated chitosan nanoparticles for oral delivery of insulin: In vitro and ex vivo evaluation. International Journal of Pharmaceutics, 520(1-2), 22-32 (2017).

Kumar P, Pandit, JK. Development and in vitro evaluation of chitosan-alginate based mucoadhesive microspheres for the sustained and targeted delivery of Metronidazole. International Journal of Pharmaceutics, 471(1-2), 221-230 (2014).

Feng S, Yu Y, Wang Y, Zhu D. Preparation and evaluation of pH-sensitive chitosan/hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles for oral delivery of Metronidazole. Colloids and Surfaces B: Biointerfaces, 144, 306-313 (2016).

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2019). ICH Q1A: Stability testing of new drug substances and products. https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-and-drug-products-scientific-guideline

Mathews BR. Regulatory aspects of stability testing in Europe. Drug Development Industrial Pharmacy, 25 (7), 831-856 (1999).

Published

2024-02-29

How to Cite

Chechare, D. D., & Siddaiah, M. (2024). Formulation and evaluation of mucoadhesive microspheres of metronidazole. Journal of Applied Pharmaceutical Research, 12(1), 93-99. https://doi.org/10.18231/j.joapr.2024.12.1.93.99

Issue

Section

Articles